Phacilitate Leaders Forum

17th -18th SEPTEMBER 2019

ROYAL LANCASTER LONDON

Investment for Advanced Therapies - Report

Investment for Advanced Therapies - Report

The advanced therapy sector is a rapidly growing industry which offers substantial investment opportunities for those able to understand and overcome the significant challenges to successful commercialisation.

The industry is characterised predominantly by small, young biotechnology companies developing therapeutic agents and peripheral technologies, supported largely by academic and publicly funded basic and translational research efforts.

Investors approaching the advanced therapy sector are faced with extensive barriers but strategies for risk mitigation are increasingly established. Investors need sufficient technical understanding to assess the merit of an ATMP and be able to understand clinical and preclinical data.

In partnership with Biotech and Money, we’ve produced a 115-page report detailing and analysing this, as well as the wider challenges and opportunities of the advanced therapy sector.

Investors and biotechs are coming together to at the Phacilitate Leaders Europe this September in London. Find out more about the event here or go straight to the agenda.

The Report


 

 

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
    Celyad
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd